Key Metrics
CiteScore 

1.6
SJR 

Q4Endocrinology, Diabetes and Metabolism

SNIP 

0.69
Recommended pre-submission checks
Powered by 

Topics Covered on Endocrinology, Diabetes and Metabolism
Endocrinology, Diabetes and Metabolism Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | EUR 1650 | GBP 1450 | USD 2200 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in Endocrinology, Diabetes and Metabolism ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Endocrinology, Diabetes and Metabolism
Glycaemic and Cardiometabolic Outcomes of Empagliflozin Versus Sitagliptin Added to Metformin in T2DM: Insights From a Systematic Review and Meta\u2010Analysis
- 12 May 2026
- Endocrinology, Diabetes & Metabolism
The Gastrointestinal Safety of Orforglipron, a GLP\u20101 Receptor Agonist, in Adults With or Without Type 2 Diabetes: A Network Meta\u2010Analysis of Randomized Controlled Trials
- 11 May 2026
- Endocrinology, Diabetes & Metabolism
How CGM Use in Adults With Type 2 Diabetes Leads to Glycemic Benefits: The Role of Medication and Behaviour Change.
- 1 May 2026
- Endocrinology, diabetes & metabolism
The Effect of Integrated Lifestyle Intervention Incorporating Calorie-Carbohydrate Restriction With or Without Time-Restricted Feeding for Remission of Type 2 Diabetes (DIREM): A Single Blind Randomised Controlled Trial.
- 1 May 2026
- Endocrinology, diabetes & metabolism
Gut Dysbiosis as a Shared Mechanism in Obesity and Hypertension: Exploring a Promising Therapeutic Avenue.
- 1 May 2026
- Endocrinology, diabetes & metabolism
Poor Glycemic Control in East Africa: Prevalence, Risk Factors and Public Health Implications in Diabetes Management.
- 1 May 2026
- Endocrinology, diabetes & metabolism
Glycaemic and Cardiometabolic Outcomes of Empagliflozin Versus Sitagliptin Added to Metformin in T2DM: Insights From a Systematic Review and Meta\u2010Analysis
- 12 May 2026
- Endocrinology, Diabetes & Metabolism
The Gastrointestinal Safety of Orforglipron, a GLP\u20101 Receptor Agonist, in Adults With or Without Type 2 Diabetes: A Network Meta\u2010Analysis of Randomized Controlled Trials
- 11 May 2026
- Endocrinology, Diabetes & Metabolism
How CGM Use in Adults With Type 2 Diabetes Leads to Glycemic Benefits: The Role of Medication and Behaviour Change.
- 1 May 2026
- Endocrinology, diabetes & metabolism
The Effect of Integrated Lifestyle Intervention Incorporating Calorie-Carbohydrate Restriction With or Without Time-Restricted Feeding for Remission of Type 2 Diabetes (DIREM): A Single Blind Randomised Controlled Trial.
- 1 May 2026
- Endocrinology, diabetes & metabolism
Gut Dysbiosis as a Shared Mechanism in Obesity and Hypertension: Exploring a Promising Therapeutic Avenue.
- 1 May 2026
- Endocrinology, diabetes & metabolism
Poor Glycemic Control in East Africa: Prevalence, Risk Factors and Public Health Implications in Diabetes Management.
- 1 May 2026
- Endocrinology, diabetes & metabolism